Autologous Bone Marrow Transplantation - Blog Science Connections

ABMT in ALL 41
(46.5% for ALL and 49.9% for ALL CR1 at 3 years) (Fig 1) is better than both
the reported results of ABMT and the allogeneic transplantation. It also
defines ABMT as a valuable approach to the management of ALL.
The evaluation of real efficacy of ex vivo bone marrow treatment with
mafosfamide needs more randomized clinical studies for a clear demonstration
of the possibility to eradicate minimal residual disease.
ACKNOWLEDGMENT
This work was supported by CNR 85.00704.04, PFO 85.02335.04 AIRC
'86 MPI 1985 40%, 60%, CNR N. 86.00280.44, 86.00463.44, 86.00703.44,
86.00559.44.
REFERENCES
1. Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Friedman A, Gee TS, Dowling M,
Kempin S, Straus DJ, Koziner B, et a/. J Clin Oncol 1983:1:462.
2. Gale RP, Champlin RE. In Recent Advances in Bone Marrow Transplantation. Gale RP, ed.
Alan R. Liss, New York, 1983.
3. Gorin NC, Herve P, Aegerter P, Goldstone A, Linch D, Maraninchi D, Burnett A, Helbig W,
Meloni G, Verdonck LF, de Witte T, Rizzoli V, Carella A, Parlier Y, Auvert B, Goldman J, for the
Working Party on Autologous Bone Marrow Transplantation of the European Bone Marrow
Transplantation Group (EBMTG)! Br J Haematol 1986:64:385.
4. Yeager AM, Kaizer H, Santos GW, Sarai R, Colvin OM, Stuart RK, Braine HG, Burke PJ,
Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May AS, Rowley SD,
Sensenbrenner LL, Vogelsang GB, Wingard JR. N Engl J Med 1986;315:141.
5. Anderson CC, Linch DC, Jones M, Closs SP, Cawley JC, Richards JDN, Goldstone AH. Br J
Haematol 1984:57:196.
6. Dicke KA, Zander A, Spitzer G, Verma DS, Peters L, Vellekoop L, McCredie KB, Hester J.
Lancet 1979:1:514.
7. Ramsay N, LeBien T, Nesbit M, McGlave P, Weisdorf D, Kenyon P, Hurd D, Goldman A, Kim T,
Kersey J. Blood 1985:66:508.
8. Anderson KC, Sallan S, Takvorian T, et al. Int J Cell Cloning 1985:3:239 (abstract).
9. Sharkis SJ, Santos GW, Colvin M. Blood 1980:55:521.
10. Takamizawa A, Matsumoto S, Iwata T, Katagiri K, Tochino Y, Yamaguchi K. J Am Chem Soc
1973:95:985.
11. Kaizer H, Stuart RK, Brookmeyer R, Beschomer WE, Braine HG, Burns WH, Fuller DJ,
Korbling M, Mangan KF, Sarai R, et al. Blood 1985:65:1504.
12. Kaplan EM, Meier P. Journal of the American Statistical Association 1958;53:457.
13. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE,
Singer JW, Shulman H, Storb R, Weiden PL. N Engl J Med 1979:301:597.
14. Gale RP, Kay HEM, Rimm AA, Boitin MM. Lancet 1982;2:1006.
15. Barrett AJ, Kendra JR, Lucas CF, Joss DV, Joshi R, Desai M, Hugh-Jones K, Phillips RH,
Rogers TR, Tabara Z, Williamson S, Hobbs JR, et al. Br J Haematol 1982;52:181.
16. Gale RP, Kersey JH, Boitin MM, Dicke KA, Good RA, Zwaan FE, Rimm AA. Lancet
1983:2:663.
17. Rizzoli V, Mangoni L, Degliantoni G, Caramatti C, Costi D, Craviotto L. Int J Cell Cloning
1985:3:246.
18. Flesch M, Herve P. In Recent Advances in Autologous Bone Marrow Transplantation in
Onco-haematology, Herve P, Gorin NC, eds. Librairie Arnette, Paris, 1985:489.